Our results are in accordance to those of the two recent meta-analyses of vitamin E’s effect on NAFLD [20,38] with ALT levels being further decreased compared with AST levels in all subgroups. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.